Skip to main content

Pharmacy

By Beth Jones Sanborn | 01:58 pm | June 19, 2017
Expert Julie Hurley will address pitfalls in "Securing and Illuminating the Pharmaceutical Supply Chain" webinar Wednesday.
By Kaiser Health News | 10:53 am | June 19, 2017
Documents reveal behind-the-scenes discussions influenced by pharmaceutical industry, led by former Gilead lobbyist Joe Grogan.
By Jeff Lagasse | 11:22 am | June 13, 2017
Some high-priced drugs like Sovaldi, a hepatitis C drug which initially cost $84,000, involved no rebates until other competitors came to market.
By Kaiser Health News | 10:53 am | June 08, 2017
Costs for prescription drugs have been rising faster than those for any other health segment, marked by high-profile cases like EpiPen and Daraprim.
By Kaiser Health News | 01:06 pm | June 07, 2017
Many of the 1.25 million Americans who live with Type 1 diabetes cheered the effort as an important first step in their fight against soaring costs.
By Jeff Lagasse | 12:57 pm | May 22, 2017
The findings suggest that the move by CMS to remove pain management from consideration will have little effect on hospital payments.
By Jeff Lagasse | 03:54 pm | May 15, 2017
Best way to address these problems is to create greater transparency, and simplify the pricing structure, PRI says.
By Jessica Davis | 12:23 pm | May 10, 2017
Scott Gottlieb and Gopal Khanna round out the most recent government hires to head the agencies most important to health IT.
By Kaiser Health News | 10:43 am | May 10, 2017
Researchers found nearly a third of approvals from 2001 through 2010 had major safety issues years after they were widely available to patients.|
By Susan Morse | 01:41 pm | May 08, 2017
Health plans need stability, the former CMS leader says, to be able to offer high-quality and affordable coverage.